NS · Pharmaceuticals

Sai Life Sciences Ltd (SAILIFE)

Pharmaceuticals & Biotechnology

Sai Life Sciences Ltd (SAILIFE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $256.74B, P/E ratio is 75.20. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SAILIFE

Market cap

$256.74B

P/E ratio

75.20

Sai Life Sciences Ltd (SAILIFE) — FAQ

What is Sai Life Sciences Ltd's market cap?

Sai Life Sciences Ltd (SAILIFE) has a reported market cap of $256.74B (data as of 2026-07-10).

What is SAILIFE's P/E ratio?

The price-to-earnings (P/E) ratio for Sai Life Sciences Ltd (SAILIFE) is 75.20 (data as of 2026-07-10).

Does Sai Life Sciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sai Life Sciences Ltd (SAILIFE). Check the MyAverix Finance app for the latest dividend data.

What sector is Sai Life Sciences Ltd in?

Sai Life Sciences Ltd (SAILIFE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is SAILIFE listed on?

SAILIFE is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)